Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TheraCal PT Versus Formocresol in Primary Molar Pulpotomies: Clinical and Radiographic Outcomes at 12 Months Follow-Up

NCT07864181 is registered in ClinicalTrials.gov with Hama University as lead sponsor.

NCT NCT07864181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07864181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TheraCal PT Versus Formocresol in Primary Molar Pulpotomies: Clinical and Radiographic Outcomes at 12 Months Follow-Up
Lead sponsor
Hama University
Phase
Phase 1/2
Overall status
Completed
Start date
January 1, 2024
Completion date
December 23, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

reversible pulpitis